Philips Respironics, Inc.: Philips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-use ventilator device.
Read the official notice at FDA (device) →
Get alerts for Philips Respironics
The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.
- Company / brand
- Philips Respironics, Inc.
- Product
- Philips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-use ventilator device.
- Reason / hazard
- Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
- Classification
- Class I
- Status
- Ongoing
- Distribution / sold at
- Worldwide distribution: US (Nationwide) and OUS (Foreign) to countries of: Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgium, Bulgaria, Bolivia, Brazil, Bahamas, Canada, Switzerland, Chile, China, Colombia, Czech Republic, Germany, Denmark, Algeria, Ecuador, Estonia, Egypt, Spain, Finland, France, Georgia, French Guiana, Gibraltar, Greece, Guatemala, Hong Kong, Croatia, Hungary, Indonesia, Ireland, Israel, India, Italy, Jersey, Jordan, Japan, Kenya, South Korea, Kuwait, Lebanon, Lithuania, Morocco, Montenegro, North Macedonia, Myanmar, Martinique, Malta, Mexico, Malaysia, Nigeria, Netherlands, Norway, Nepal, New Zealand, Oman, Panama, Peru, French Polynesia, Philippines, Pakistan, Poland, Portugal, Paraguay, Qatar, R¿union, Romania, Serbia, Russia, Saudi Arabia, Sweden, Singapore, Slovenia, Slovakia, Thailand, Tunisia, Turkey, Taiwan, Ukraine, United Arab Emirates, United Kingdom, Vietnam, Mayotte, South Africa, Zimbabwe.
- Recall initiated
- 2026-03-02
- Code info
- All Model No.; All UDI; All Serial No.
- Product quantity
- 113,717 units
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Murrysville
- State
- PA
- Country
- United States
- Event id
- 98537
Free daily digest + "My products" watchlist